Skip to main content
CDC Website

HIV

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to co-infections (excluding co-infection with human immunodeficiency virus [HIV]) that engendered novel opportunities for prevention and treatment and focus on understudied populations.

Desigualdades Peligrosas [Dangerous Inequalities: World AIDS Day report 2022]

This report, which marks World AIDS Day 2022, unpacks the impact that gender inequalities, inequalities faced by key populations, and inequalities between children and adults have had on the AIDS response. It is not inevitable, however, that these inequalities will slow progress towards ending AIDS.

Inégalités Dangereuses [Dangerous Inequalities: World AIDS Day report 2022]

This report, which marks World AIDS Day 2022, unpacks the impact that gender inequalities, inequalities faced by key populations, and inequalities between children and adults have had on the AIDS response. It is not inevitable, however, that these inequalities will slow progress towards ending AIDS.

التفاوتات الخطيرة [Dangerous Inequalities: World AIDS Day report 2022]

This report, which marks World AIDS Day 2022, unpacks the impact that gender inequalities, inequalities faced by key populations, and inequalities between children and adults have had on the AIDS response. It is not inevitable, however, that these inequalities will slow progress towards ending AIDS.

Dangerous Inequalities: World AIDS Day report 2022

This report, which marks World AIDS Day 2022, unpacks the impact that gender inequalities, inequalities faced by key populations, and inequalities between children and adults have had on the AIDS response. It is not inevitable, however, that these inequalities will slow progress towards ending AIDS.

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID.

20.2 million girls and women living with HIV

This infographic discusses how girls and women make up more than half of the 37.7 million people living with HIV. Ending AIDS by 2030 requires that we address girls’ and women’s diverse roles by putting them at the centre of the response.